Patients were to be randomized to 1200 mg, 450 mg, or placebo, administered intravenously daily for 3 days followed by weekly for 4 weeks
It begins below the obesity-trial floor because appetite and gastrointestinal effects need time to adapt before escalation. At 5 mg, both GIP and GLP-1 are clinically active
Once the tissue is restored to its 2026 standard of functional integrity, the protocol should be tapered off to allow the bodys natural homeostasis to return
Disclaimer: The following information is not medical advice and is based on animal studies, preclinical research, and consumer testimonials
The authors cited the scientific foundation provided by these studies as supporting ongoing and projected clinical trials in dermal wound repair, corneal injuries, and cardiac and CNS tissue regeneration